If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Endometrial Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hereditary Nonpolyposis Colorectal Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
DNA Mismatch Repair Medicine & Life Sciences
Microsatellite Instability Medicine & Life Sciences
Genes Medicine & Life Sciences
Germ-Line Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition

Kawaguchi, R., Matsumoto, K., Akira, S., Ishitani, K., Iwasaku, K., Ueda, Y., Okagaki, R., Okano, H., Oki, T., Koga, K., Kido, M., Kurabayashi, T., Kuribayashi, Y., Sato, Y., Shiina, K., Takai, Y., Tanimura, S., Chaki, O., Terauchi, M., Todo, Y. & 14 othersNoguchi, Y., Nose-Ogura, S., Baba, T., Hirasawa, A., Fujii, T., Fujii, T., Maruyama, T., Miyagi, E., Yanagida, K., Yoshino, O., Iwashita, M., Maeda, T., Minegishi, T. & Kobayashi, H., Apr 1 2019, In : Journal of Obstetrics and Gynaecology Research. 45, 4, p. 766-786 21 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death

Ueno, M., Shiomi, T., Mochizuki, S., Chijiiwa, M., Shimoda, M., Kanai, Y., Kataoka, F., Hirasawa, A., Susumu, N., Aoki, D. & Okada, Y., Feb 1 2018, In : Cancer Science. 109, 2, p. 471-482 12 p.

Research output: Contribution to journalArticle

Cell Death

GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: A comprehensive analysis using targeted resequencing of 100 pharmacogenes

Yoshihama, T., Fukunaga, K., Hirasawa, A., Nomura, H., Akahane, T., Kataoka, F., Yamagami, W., Aoki, D. & Mushiroda, T., Jul 1 2018, In : Oncotarget. 9, 51, p. 29789-29800 12 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Ovarian Neoplasms
Fallopian Tube Neoplasms
2 Citations (Scopus)

Is repeated high-dose medroxyprogesterone acetate (Mpa) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

Yamagami, W., Susumu, N., Makabe, T., Sakai, K., Nomura, H., Kataoka, F., Hirasawa, A., Banno, K. & Aoki, D., Mar 1 2018, In : Journal of Gynecologic Oncology. 29, 2, e21.

Research output: Contribution to journalArticle

Endometrial Hyperplasia
Medroxyprogesterone Acetate
Endometrial Neoplasms
2 Citations (Scopus)

A comparison of dye versus fluorescence methods for sentinel lymph node mapping in endometrial cancer

Yamagami, W., Susumu, N., Kataoka, F., Makabe, T., Sakai, K., Ninomiya, T., Wada, M., Nomura, H., Hirasawa, A., Banno, K., Nakahara, T., Kameyama, K. & Aoki, D., Jan 1 2017, In : International Journal of Gynecological Cancer. 27, 7, p. 1517-1524 8 p.

Research output: Contribution to journalArticle

Endometrial Neoplasms
Coloring Agents
Indocyanine Green